Trial Profile
A Phase IB/IIA, Multicenter, Open-label, Clinical Trial to Evaluate the safety, tolerability and pharmacokinetic of Desidustat for the patients with Chronic Kidney Disease (CKD) on Dialysis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 29 Apr 2019
Price :
$35
*
At a glance
- Drugs Desidustat (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 24 Apr 2019 Status changed from recruiting to completed.
- 13 Nov 2018 New trial record